Alss Secures $7M in Series B Funding

Applied LifeSciences & Systems

Applied LifeSciences & Systems (ALSS), a Morrisville, NC-based biomedical systems company, held the initial close of a $7m Series B equity financing.

The round was co-led by Merck Animal Health and Mountain Group Partners with participation from Oval Park Capital.

The company intends to use the funds to accelerate the commercialization of its automated and individualized poultry vaccination systems.

Led by Ramin Karimpour, Founder and CEO, ALSS integrates its proprietary technologies in high-speed imaging, feature recognition, artificial intelligence, robotics and microfluidics in a system currently developed for the commercial poultry industry. This system can individually and accurately vaccinate up to 100,000 chicks per hour against diseases such as coccidiosis, infectious bronchitis and Newcastle disease.